COVID-19 Impact on Global Pandemic Influenza Vaccine Market Insights, Forecast to 2026
Pandemic Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pandemic Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pandemic Influenza Vaccine market is segmented into
The Pandemic Influenza Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pandemic Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pandemic Influenza Vaccine Market Share Analysis
Pandemic Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pandemic Influenza Vaccine business, the date to enter into the Pandemic Influenza Vaccine market, Pandemic Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Pandemic Influenza Vaccine market is segmented into
- Influenza A (H1N1) Vaccines
- Other
- Adult
- Paediatric
The Pandemic Influenza Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pandemic Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pandemic Influenza Vaccine Market Share Analysis
Pandemic Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pandemic Influenza Vaccine business, the date to enter into the Pandemic Influenza Vaccine market, Pandemic Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
- AstraZeneca
- GlaxoSmithKline
- Novartis
- Sanofi
- Valneva
- Lupin
- Chiron Panacea
- Solvay and Serum Institute of India Pvt. Ltd.
- Sementis
1 STUDY COVERAGE
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pandemic Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Influenza A (H1N1) Vaccines
1.4.3 Other
1.5 Market by Application
1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Paediatric
1.6 Coronavirus Disease 2019 (Covid-19): Pandemic Influenza Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pandemic Influenza Vaccine Industry
1.6.1.1 Pandemic Influenza Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pandemic Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pandemic Influenza Vaccine Revenue 2015-2026
2.1.2 Global Pandemic Influenza Vaccine Sales 2015-2026
2.2 Pandemic Influenza Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PANDEMIC INFLUENZA VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2019
3.2.5 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pandemic Influenza Vaccine Price by Manufacturers
3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pandemic Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pandemic Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pandemic Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pandemic Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Pandemic Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Pandemic Influenza Vaccine Price by Application (2015-2020)
5.2 Pandemic Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pandemic Influenza Vaccine by Country
6.1.1 North America Pandemic Influenza Vaccine Sales by Country
6.1.2 North America Pandemic Influenza Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Type
6.3 North America Pandemic Influenza Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pandemic Influenza Vaccine by Country
7.1.1 Europe Pandemic Influenza Vaccine Sales by Country
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Type
7.3 Europe Pandemic Influenza Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pandemic Influenza Vaccine by Region
8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region
8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pandemic Influenza Vaccine by Country
9.1.1 Latin America Pandemic Influenza Vaccine Sales by Country
9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Type
9.3 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pandemic Influenza Vaccine by Country
10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country
10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Pandemic Influenza Vaccine Products Offered
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description, Business Overview and Total Revenue
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
11.4.5 Sanofi Recent Development
11.5 Valneva
11.5.1 Valneva Corporation Information
11.5.2 Valneva Description, Business Overview and Total Revenue
11.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Valneva Pandemic Influenza Vaccine Products Offered
11.5.5 Valneva Recent Development
11.6 Lupin
11.6.1 Lupin Corporation Information
11.6.2 Lupin Description, Business Overview and Total Revenue
11.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lupin Pandemic Influenza Vaccine Products Offered
11.6.5 Lupin Recent Development
11.7 Chiron Panacea
11.7.1 Chiron Panacea Corporation Information
11.7.2 Chiron Panacea Description, Business Overview and Total Revenue
11.7.3 Chiron Panacea Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
11.7.5 Chiron Panacea Recent Development
11.8 Solvay and Serum Institute of India Pvt. Ltd.
11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
11.8.2 Solvay and Serum Institute of India Pvt. Ltd. Description, Business Overview and Total Revenue
11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
11.9 Sementis
11.9.1 Sementis Corporation Information
11.9.2 Sementis Description, Business Overview and Total Revenue
11.9.3 Sementis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sementis Pandemic Influenza Vaccine Products Offered
11.9.5 Sementis Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pandemic Influenza Vaccine Market Estimates and Projections by Region
12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pandemic Influenza Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pandemic Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Pandemic Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Influenza A (H1N1) Vaccines
1.4.3 Other
1.5 Market by Application
1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Paediatric
1.6 Coronavirus Disease 2019 (Covid-19): Pandemic Influenza Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pandemic Influenza Vaccine Industry
1.6.1.1 Pandemic Influenza Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pandemic Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pandemic Influenza Vaccine Revenue 2015-2026
2.1.2 Global Pandemic Influenza Vaccine Sales 2015-2026
2.2 Pandemic Influenza Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PANDEMIC INFLUENZA VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2019
3.2.5 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pandemic Influenza Vaccine Price by Manufacturers
3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pandemic Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Pandemic Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pandemic Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pandemic Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Pandemic Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Pandemic Influenza Vaccine Price by Application (2015-2020)
5.2 Pandemic Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pandemic Influenza Vaccine by Country
6.1.1 North America Pandemic Influenza Vaccine Sales by Country
6.1.2 North America Pandemic Influenza Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Type
6.3 North America Pandemic Influenza Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pandemic Influenza Vaccine by Country
7.1.1 Europe Pandemic Influenza Vaccine Sales by Country
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Type
7.3 Europe Pandemic Influenza Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pandemic Influenza Vaccine by Region
8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region
8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pandemic Influenza Vaccine by Country
9.1.1 Latin America Pandemic Influenza Vaccine Sales by Country
9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Type
9.3 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pandemic Influenza Vaccine by Country
10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country
10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Pandemic Influenza Vaccine Products Offered
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description, Business Overview and Total Revenue
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
11.4.5 Sanofi Recent Development
11.5 Valneva
11.5.1 Valneva Corporation Information
11.5.2 Valneva Description, Business Overview and Total Revenue
11.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Valneva Pandemic Influenza Vaccine Products Offered
11.5.5 Valneva Recent Development
11.6 Lupin
11.6.1 Lupin Corporation Information
11.6.2 Lupin Description, Business Overview and Total Revenue
11.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lupin Pandemic Influenza Vaccine Products Offered
11.6.5 Lupin Recent Development
11.7 Chiron Panacea
11.7.1 Chiron Panacea Corporation Information
11.7.2 Chiron Panacea Description, Business Overview and Total Revenue
11.7.3 Chiron Panacea Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
11.7.5 Chiron Panacea Recent Development
11.8 Solvay and Serum Institute of India Pvt. Ltd.
11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
11.8.2 Solvay and Serum Institute of India Pvt. Ltd. Description, Business Overview and Total Revenue
11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
11.9 Sementis
11.9.1 Sementis Corporation Information
11.9.2 Sementis Description, Business Overview and Total Revenue
11.9.3 Sementis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sementis Pandemic Influenza Vaccine Products Offered
11.9.5 Sementis Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pandemic Influenza Vaccine Market Estimates and Projections by Region
12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pandemic Influenza Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pandemic Influenza Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pandemic Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Pandemic Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Pandemic Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Influenza A (H1N1) Vaccines
Table 5. Major Manufacturers of Other
Table 6. COVID-19 Impact Global Market: (Four Pandemic Influenza Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pandemic Influenza Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
Table 11. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Pandemic Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Pandemic Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 14. Global Pandemic Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Pandemic Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019)
Table 20. Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pandemic Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 23. Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pandemic Influenza Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 28. Global Pandemic Influenza Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pandemic Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pandemic Influenza Vaccine Revenue Share by Type (2015-2020)
Table 31. Pandemic Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 33. Global Pandemic Influenza Vaccine Sales Share by Application (2015-2020)
Table 34. North America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 35. North America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 39. North America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 41. North America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 43. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 47. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 49. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Major Businesses
Table 76. AstraZeneca Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. AstraZeneca Product
Table 78. AstraZeneca Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Major Businesses
Table 91. Sanofi Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi Product
Table 93. Sanofi Recent Development
Table 94. Valneva Corporation Information
Table 95. Valneva Description and Major Businesses
Table 96. Valneva Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Valneva Product
Table 98. Valneva Recent Development
Table 99. Lupin Corporation Information
Table 100. Lupin Description and Major Businesses
Table 101. Lupin Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Lupin Product
Table 103. Lupin Recent Development
Table 104. Chiron Panacea Corporation Information
Table 105. Chiron Panacea Description and Major Businesses
Table 106. Chiron Panacea Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Chiron Panacea Product
Table 108. Chiron Panacea Recent Development
Table 109. Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
Table 110. Solvay and Serum Institute of India Pvt. Ltd. Description and Major Businesses
Table 111. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Solvay and Serum Institute of India Pvt. Ltd. Product
Table 113. Solvay and Serum Institute of India Pvt. Ltd. Recent Development
Table 114. Sementis Corporation Information
Table 115. Sementis Description and Major Businesses
Table 116. Sementis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Sementis Product
Table 118. Sementis Recent Development
Table 119. Global Pandemic Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 120. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Pandemic Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 124. North America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 126. Europe: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 128. Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 130. Latin America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 132. Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Pandemic Influenza Vaccine Players
Table 137. Pandemic Influenza Vaccine Customers List
Table 138. Pandemic Influenza Vaccine Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Pandemic Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Pandemic Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Influenza A (H1N1) Vaccines
Table 5. Major Manufacturers of Other
Table 6. COVID-19 Impact Global Market: (Four Pandemic Influenza Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pandemic Influenza Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
Table 11. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Pandemic Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Pandemic Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 14. Global Pandemic Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Pandemic Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019)
Table 20. Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pandemic Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 23. Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pandemic Influenza Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 28. Global Pandemic Influenza Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pandemic Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pandemic Influenza Vaccine Revenue Share by Type (2015-2020)
Table 31. Pandemic Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 33. Global Pandemic Influenza Vaccine Sales Share by Application (2015-2020)
Table 34. North America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 35. North America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 39. North America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 41. North America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 43. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 47. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 49. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Major Businesses
Table 76. AstraZeneca Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. AstraZeneca Product
Table 78. AstraZeneca Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Major Businesses
Table 91. Sanofi Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Sanofi Product
Table 93. Sanofi Recent Development
Table 94. Valneva Corporation Information
Table 95. Valneva Description and Major Businesses
Table 96. Valneva Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Valneva Product
Table 98. Valneva Recent Development
Table 99. Lupin Corporation Information
Table 100. Lupin Description and Major Businesses
Table 101. Lupin Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Lupin Product
Table 103. Lupin Recent Development
Table 104. Chiron Panacea Corporation Information
Table 105. Chiron Panacea Description and Major Businesses
Table 106. Chiron Panacea Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Chiron Panacea Product
Table 108. Chiron Panacea Recent Development
Table 109. Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
Table 110. Solvay and Serum Institute of India Pvt. Ltd. Description and Major Businesses
Table 111. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Solvay and Serum Institute of India Pvt. Ltd. Product
Table 113. Solvay and Serum Institute of India Pvt. Ltd. Recent Development
Table 114. Sementis Corporation Information
Table 115. Sementis Description and Major Businesses
Table 116. Sementis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Sementis Product
Table 118. Sementis Recent Development
Table 119. Global Pandemic Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 120. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Pandemic Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 124. North America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 126. Europe: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 128. Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 130. Latin America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 132. Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Pandemic Influenza Vaccine Players
Table 137. Pandemic Influenza Vaccine Customers List
Table 138. Pandemic Influenza Vaccine Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Influenza A (H1N1) Vaccines Product Picture
Figure 4. Other Product Picture
Figure 5. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Paediatric
Figure 8. Pandemic Influenza Vaccine Report Years Considered
Figure 9. Global Pandemic Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Pandemic Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 11. Global Pandemic Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pandemic Influenza Vaccine Revenue in 2019
Figure 18. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 21. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Pandemic Influenza Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Pandemic Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 26. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2019
Figure 28. North America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 31. North America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 32. U.S. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 37. North America Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 38. Europe Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 41. Europe Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 42. Germany Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 53. Europe Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 54. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 58. China Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 81. Asia Pacific Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 82. Latin America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 85. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 86. Mexico Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 93. Latin America Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 94. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 105. Middle East and Africa Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 106. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Chiron Panacea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Solvay and Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sementis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. North America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Europe Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 122. Latin America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 124. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Influenza A (H1N1) Vaccines Product Picture
Figure 4. Other Product Picture
Figure 5. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Paediatric
Figure 8. Pandemic Influenza Vaccine Report Years Considered
Figure 9. Global Pandemic Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Pandemic Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 11. Global Pandemic Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pandemic Influenza Vaccine Revenue in 2019
Figure 18. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 21. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Pandemic Influenza Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Pandemic Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 26. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2019
Figure 28. North America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 31. North America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 32. U.S. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 37. North America Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 38. Europe Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 41. Europe Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 42. Germany Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 53. Europe Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 54. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region in 2019
Figure 58. China Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 81. Asia Pacific Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 82. Latin America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 85. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 86. Mexico Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 93. Latin America Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 94. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pandemic Influenza Vaccine Market Share by Type in 2019
Figure 105. Middle East and Africa Pandemic Influenza Vaccine Market Share by Application in 2019
Figure 106. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Chiron Panacea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Solvay and Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sementis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. North America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Europe Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 122. Latin America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 124. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
